Brief overview: cemiplimab for the treatment of advanced basal cell carcinoma: PD-1 strikes again.
Davis CM, Lewis KD. Brief overview: cemiplimab for the treatment of advanced basal cell carcinoma: PD-1 strikes again. Ther Adv Med Oncol. 2022; 14:17588359211066147.